title: Provider-caregiver-child discussions about risks associated with asthma control medications: content and prevalence.
abstract: OBJECTIVE
  The objectives of this study were to: (1) describe the extent to which general pediatric providers discuss risks associated with asthma control medications with families, and (2) examine factors that are associated with risk discussions.
  
  
  METHODS
  This study was a cross-sectional secondary analysis of audio taped medical visits involving 35 pediatric providers and 248 children with asthma with their caregivers. Transcripts of the visits were coded for discussions about asthma medication risks. Generalized estimating equations were used to analyze the data.
  
  
  RESULTS
  Providers discussed asthma control medication risks during 23% of visits. Risks were more likely to be discussed when the visit was longer and when the provider prescribed a new asthma control medication. When providers discussed asthma control medication risks, they were most likely to ask the family general questions and make general statements. Across all of the visits, caregivers asked a total of 16 questions and made a total of 20 statements about risks associated with asthma medications; children asked a total of 3 questions and made two statements about risks associated with asthma control medications.
  
  
  CONCLUSIONS
  Providers discussed risks associated with asthma control medications in less than one-quarter of medical visits. Providers should involve families in discussions about risks associated with medications during every visit to assess potential barriers to medication adherence.
authors.affiliation: Department of Pharmacy Practice, Administration, and Research, Marshall University School of Pharmacy, Huntington, West Virginia.
authors.forename: Chris
authors.initials: C
authors.lastname: Gillette
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Blalock
authors.forename: Jaya K
authors.initials: JK
authors.lastname: Rao
authors.forename: Dennis
authors.initials: D
authors.lastname: Williams
authors.forename: Ceila E
authors.initials: CE
authors.lastname: Loughlin
authors.forename: Betsy
authors.initials: B
authors.lastname: Sleath
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy*; D017028:Caregivers; D002648:Child; D003142:Communication; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D010353:Patient Education as Topic; D010817:Physician-Patient Relations; D010818:Practice Patterns, Physicians'; D011368:Professional-Family Relations; D012306:Risk
chemical_list: D018927:Anti-Asthmatic Agents
keywords: adverse effects; asthma; communication